Industry Segment: Market Brief | Word Count: 86 Words
Attachment: LA COVID 0620

Companies in Latin America's Pharmaceutical & Biotech Industry have delayed the authorizations for expenditure on 93 capital-spending projects, with a total investment value of more than $245 million, during the second quarter of 2020. This period has seen a tightening of lockdowns and restrictions related to the COVID-19 pandemic.